Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.

New GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India's top endocrinologist, in an episode of Booked, highlights the impact of ...

There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...

Ireland’s medicines watchdog has confirmed a number of reports of pancreatitis linked to weight loss jabs. GLP-1 drugs like Ozempic and Mounjaro are under review in the UK after a spike in adverse ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

There are a few potential risks to keep in mind with rice water, including some food safety concerns.

Mounjaro users in the UK have to jump through quite a few hoops to get their hands on the weight-loss drug. You might think ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

Patients have reported being hospitalised with inflammation of the pancreas suspected to be related to medicines such as ...

Maria AbiHanna, a Dubai-based dietician said six certain food groups 'can do the same thing naturally, without the nausea'.